Last reviewed · How we verify

NCT04323865

Fetal Heart Rate Variability

Completed Last updated 23 November 2020
What this trial tests

trial testing fetal heart rate variability in Fetal Growth Retardation in 75 participants. Completed in 1 February 2020.

Timeline
1 June 2018
Primary endpoint
1 February 2020
1 February 2020

Quick facts

Lead sponsorUniversity of Aarhus
StatusCompleted
Study typeOBSERVATIONAL
Enrollment75
Start date1 June 2018
Primary completion1 February 2020
Estimated completion1 February 2020
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Aarhus

Who can join

Eligibility, female only, with Fetal Growth Retardation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Need statement \- a new way to distinguish between a healthy small fetus and a small fetus suffering from deprivation of nutrition and oxygen to prevent unnecessary induction of preterm birth and improve neonatal outcome. Aim - to characterize fetal heart rate variability (fHRV) based on fetal ECG in the normal fetus and in the fetus suffering from growth retardation to evaluate its value and applicability as a supplementary tool in fetal surveillance. Aim of current study \- To evaluate the feasibility of NI-FECG from gestational week 20 and onwards and investigate if important factors as length and heart rate pattern affects repeatability of time domain and spectral analyses in fetuses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of fetal heart rate variability

Trials testing the same drug.

Other recruiting trials for Fetal Growth Retardation

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04323865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing